Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-673-7 | CAS number: 94944-95-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity
- Author:
- R.A. Corley et al.
- Year:
- 2 008
- Bibliographic source:
- Toxicology and Applied Pharmacology 228 (2008) 165–178
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 452 (Chronic Toxicity Studies)
- Deviations:
- yes
- Remarks:
- Test during 1 year in males only. No haematology or clinical chemistry. No behavioural examinations. The study focusses on effects on the kidney
- Principles of method if other than guideline:
- Test during 1 year in males only. No haematology or clinical chemistry. No behavioural examinations.
The study focusses on effects on the kidney - GLP compliance:
- not specified
- Remarks:
- publication
Test material
- Reference substance name:
- Ethane-1,2-diol
- EC Number:
- 203-473-3
- EC Name:
- Ethane-1,2-diol
- Cas Number:
- 107-21-1
- Molecular formula:
- C2H6O2
- IUPAC Name:
- ethylene glycol
- Details on test material:
- - Name of test material (as cited in study report): ethylene glycol
- Molecular formula (if other than submission substance): C2H6O2
- Analytical purity: 99.4%±0.07%
Constituent 1
- Specific details on test material used for the study:
- - Analytical purity: 99.4%±0.07%
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on species / strain selection:
- Based on literature suggesting that Wistar rats may be most susceptible to ethylene glycol-induced nephrotoxicity ( and that males may be more sensitive than females)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: Wistar Han (Crl:WI(Gix/BRL/Han)IGSBR
- Source: Charles River Laboratories, Inc. (Raleigh, North Carolina)
- Age at study initiation: 6 weeks
- Weight at study initiation: ca 180 g (taken from figure in publication)
- Housing: individually in stainless-steel mesh caging suspended above cageboard
- Diet: lower-protein NTP2000 diet in meal form from Zeigler Brothers, Inc., Gardners, PA ad libitum
- Water: tap water ad libitum
- Acclimation period: no data
DETAILS OF FOOD AND WATER QUALITY: not provided
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.5–22.3 °C
- Humidity (%): 48.6–63.0%.
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- DIET PREPARATION
- Rate of preparation of diet (frequency): weekly
- Mixing appropriate amounts: serially diluting a concentrated test material-feed mixture (premix) with ground feed, passing it through a Comil (Quadro Engineering Incorporated, Waterloo, Ontario) to break any small clumps, then further mixed with NTP2000 diet using a Hobart blender.
- Storage temperature of food: ambient
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- analysed for homogeneity, stability and accuracy of preparation by a solvent extraction method followed by gas chromatography/mass spectrometry
Found to be stable, no more details available - Duration of treatment / exposure:
- 1 year
- Frequency of treatment:
- continuously diet formulation concentrations were adjusted once weekly during the first 12 weeks and two-weekly thereafter
Doses / concentrationsopen allclose all
- Dose / conc.:
- 50 mg/kg bw/day (nominal)
- Dose / conc.:
- 150 mg/kg bw/day (nominal)
- Dose / conc.:
- 300 mg/kg bw/day (nominal)
- Dose / conc.:
- 400 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 10 males/dose (an additional 5 males/ dose for analysis of ethylene glycol, glycolic acid and oxalic acid in blood, kidneys and urine
- Control animals:
- yes, plain diet
- Details on study design:
- - Dose selection rationale: based on a 16 weeks study with a NOAEL for renal toxicity in both male Wistar and F344 rats at 150 mg/kg/day and severe effects at 500 and 1000 mg/kg bw
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: (bi)-weekly
BODY WEIGHT: Yes
- Time schedule for examinations:weekly (first 12 weeks)/bi -weekly
FOOD CONSUMPTION AND COMPOUND INTAKE : weekly adjusted for first 12 weeks, bi-weekly thereafter
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Not specified
- Compound intake calculated based food consumption and body weight data: Yes
FOOD EFFICIENCY: not specified
WATER CONSUMPTION; Yes
- Time schedule for examinations: at study end during over a 24 hour period
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: No
CLINICAL CHEMISTRY: No
URINALYSIS: Yes
- Time schedule for collection of urine: at study end over a 24 hour period
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Not specified
- Parameters checked: Specific gravity, pH, color, and appearance
Semiquantitative analysis of pH, bilirubin, glucose, protein, ketones, occult blood, and urobilinogen
Microscopic evaluation of crystal types via micro-sediment analysis .
NEUROBEHAVIOURAL EXAMINATION: No
IMMUNOLOGY: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes on all animals not further specified
ORGAN WEIGHTS: Liver and kidney
HISTOPATHOLOGY: Yes on kidneys by light and fluorescence microscopy (half used, with other half used for metabolite analysis) and urinary bladder - Statistics:
- Statistical analyses were conducted using SAS/STAT Software Version 6 or Prism 4 for Windows. Means and standard deviations were calculated for all continuous data. Body weights, feed consumption, organ weights, urine volume, and urine specific gravity were evaluated by Bartlett's test for equality of variances (alpha = 0.01; Winer, 1971). Based on the outcome of Bartlett's test, exploratory data analyses were performed by a parametric (Steel and Torrie, 1960) or nonparametric analysis of variance (ANOVA; Hollander and Wolfe, 1973). If the ANOVA was significant at alpha = 0.05, it was followed, sequentially, by Dunnett's test (Winer, 1971) or the Wilcoxon Rank-Sum test (Hollander and Wolfe, 1973) with a Bonferroni correction for multiple comparisons to the control (Miller, 1966). Metabolite levels were evaluated by a one-way analysis of variance (with log transformation of the data) followed by Dunnett's test to compare each treatment group to controls.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- at 300 and 400 mg/kg bw not specified
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- 1 male at 0 and 150 mg/kg bw (non-treatment related, spontaneous lymphoid tumor)
5 males at 300 mg/kg bw ( found dead or killed in extremis)
4 males at 500 mg/kg bw before day 203 (found dead or killed in extremis): 16 males at 400 mg/kg bw (killed in extremis on day 203) - Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- at 400 mg/kg bw excessive body weight loss (therefore animals were terminated on day 203)
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- at 400 mg/kg bw: sign decreased food consumption
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- effects observed, non-treatment-related
- Description (incidence and severity):
- increased at 300 mg/kg bw (150% of controls)
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- effects observed, treatment-related
- Description (incidence and severity):
- at 300 mg/kg bw:increased pH (related to metabolic products); increased volume and concomitantly decreased specific gravity compared to controls
Increased calcium oxalate crystals in the urine of the 50, 150, and 300 mg/kg/day groups. - Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- at 300 and 4000 mg/kg bw increased absolute and relative kidney weights (DR)
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- at 300 mg/kg bw: calculi in the bladder and sometimes the renal pelvis or ureter in 8 of the total 15 rats (in non survivors hemorrhage of the bladder wall, usually with ascites or other edematous changes)
at 400 mg/kg bw: calculi in the bladder and sometimes the renal pelvis or ureter in 8 of the total 20 rats, a roughened kidney surface, renal pelvic dilatation, thickened bladder wall (early decedents hemorrhage of the bladder wall) - Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- at 300 mg/kg bw : nephropathy associated with crystal deposition in most animals
at 400 mg/kg bw : nephropathy associated with crystal deposition in all animals
Light microscopy
Observed as foci, radial tracts, or diffuse areas of basophilic tubules in the cortex, and outer and inner medulla. The cytoplasm of basophilic proximal tubule cells was foamy, finely vacuolated, or rarefied, with an occasional apoptotic cell or mitotic figure, and mild basement membrane thickening. There was minimal to mild mononuclear inflammatory infiltration and fibrosis accompanying the basophilic alteration. Increasing severity of the nephropathy was manifested by coalescence of foci into areas of diffuse change and an association with tubule dilatation, increasing fibrosis, increasing extracellular matrix, minor tubulitis associated with intralumenal neutrophils, dilatation of the renal pelvis, and some transitional cell hyperplasia of the renal pelvic lining.
Fluoresence microscopy
Birefringent, polycrystalline particles arranged in rosette, fan-shaped or sheaf-like patterns, or individually as near-rectangular plates, were observed in 8 of 13 rats receiving 300 mg/kg/day, and in 10 of 10 rats receiving 400 mg/kg/day. Depending on the severity, crystal deposition occurred in the lumens of tubules from the cortex to the papilla, in outpouchings of the papilla lining, and in the renal pelvis, particularly in the fornices. - Other effects:
- not specified
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 150 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- food consumption and compound intake
- gross pathology
- histopathology: non-neoplastic
- organ weights and organ / body weight ratios
Target system / organ toxicity
- Critical effects observed:
- yes
- Lowest effective dose / conc.:
- 300 mg/kg bw/day (nominal)
- System:
- urinary
- Organ:
- bladder
- kidney
- Treatment related:
- yes
- Dose response relationship:
- yes
- Relevant for humans:
- yes
Applicant's summary and conclusion
- Conclusions:
- The NOAEL for kidney effects from this study was 150 mg/kg bw
- Executive summary:
A chronic toxicity study was conducted in male Wistar rats administered ethylene glycol via the diet at 0, 50, 150, 300, or 400 mg/kg/day for up to twelve months. Mortality occurred in 5 of 20 rats at 300 mg/kg/day (days 111–221) and 4 of 20 rats at 400 mg/kg/day (days 43–193), with remaining rats at this dose euthanized early (day 203) due to excessive weight loss. Increased water consumption and urine volume with decreased specific gravity occurred at 300 mg/kg/day presumably due to osmotic diuresis. Calculi (calcium oxalate crystals) occurred in the bladder or renal pelvis at ≥300 mg/kg bw.
Rats dying early at ≥300 mg/kg/day had transitional cell hyperplasia with inflammation and hemorrhage of the bladder wall. Crystal nephropathy (basophilic foci, tubule or pelvic dilatation, birefringent crystals in the pelvic fornix, or transitional cell hyperplasia) affected most rats at 300 mg/kg/day, all at 400 mg/kg/day, but none at ≤150 mg/kg/day.
The NOAEL of 150 mg/kg/day is the same as that reported after 16-week exposure and appears to be a threshold dose below which no renal toxicity occurs, regardless of exposure duration.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.